Repositório Covid-19

Abstract

The evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in the emergence of new variant lineages...

Abstract

We report a live-attenuated SARS-CoV-2 vaccine candidate with (i) re-engineered viral transcription regulator sequences and (ii) deleted open-reading-frames (ORF)...

Summary

Background

The protective immunity against omicron following a BNT162b2 Pfizer booster dose among elderly individuals (ie, those aged >65...

Summary

Background

Vaccination has helped to mitigate the COVID-19 pandemic. Ten traditional and novel vaccines have been listed by the...

Abstract

BACKGROUND

Limited evidence is available on the real-world effectiveness of the BNT162b2 vaccine against coronavirus disease 2019 (Covid-19) and...

Abstract

BACKGROUND

Since it was first identified in early November 2021, the B.1.1.529 (omicron) variant of severe acute respiratory syndrome...

Abstract

Cardiac involvement has been noted in COVID-19 infection. However, the relationship between post-recovery COVID-19 and development of de novo...

Summary

Background

In recent months, Omicron variants of SARS-CoV-2 have become dominant in many regions of the world, and case...

Summary

Background

Additional outpatient therapies which are readily accessible will be essential to reduce COVID-19 illness progression in high risk...

Summary

Background

The present study aims to better understand the efficacy and safety of mesenchymal stromal cells (MSCs) in treating...

Summary

Background

Whether interleukin-6 (IL-6) blockade in patients with COVID-19 will affect the protective immunity against SARS-CoV-2 has become an...

Abstract

BACKGROUND

The protection conferred by natural immunity, vaccination, and both against symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)...